Correction to Lancet Oncol 2011; 12: 625
- PMID: 26248845
- DOI: 10.1016/S1470-2045(15)00119-9
Correction to Lancet Oncol 2011; 12: 625
Erratum for
-
Carcinogenicity of radiofrequency electromagnetic fields.Lancet Oncol. 2011 Jul;12(7):624-6. doi: 10.1016/s1470-2045(11)70147-4. Lancet Oncol. 2011. PMID: 21845765 No abstract available.
Similar articles
-
Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitors.Lancet Oncol. 2015 Jul;16(7):e313. doi: 10.1016/S1470-2045(15)00082-0. Lancet Oncol. 2015. PMID: 26149882 No abstract available.
-
Correction to Lancet Oncol 2015; 16: 738. Anti-EGFR monoclonal antibodies in lung cancer treatment.Lancet Oncol. 2015 Jul;16(7):e313. doi: 10.1016/S1470-2045(15)00071-6. Lancet Oncol. 2015. PMID: 26149881 No abstract available.
-
Correction to Lancet Oncol 2015; 16: e316. New scale assesses benefits of cancer medicines.Lancet Oncol. 2015 Jul;16(7):e313. doi: 10.1016/S1470-2045(15)00056-X. Epub 2015 Jun 11. Lancet Oncol. 2015. PMID: 26149880 No abstract available.
-
Correction to Lancet Oncol 2015; 16: 447, 448.Lancet Oncol. 2015 May;16(5):e199. doi: 10.1016/S1470-2045(14)71115-5. Epub 2015 Mar 25. Lancet Oncol. 2015. PMID: 25943064 No abstract available.
-
Correction to Lancet Oncol 2013; 14: e374.Lancet Oncol. 2015 May;16(5):e199. doi: 10.1016/S1470-2045(15)70216-0. Lancet Oncol. 2015. PMID: 25943063 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources